We have a suspicion that you are an automated web bot software, not a real user. To keep our site fast for other users, we have slowed down this page. The slowdown will gradually disappear. If you think this is a mistake, please contact us at genome-www@soe.ucsc.edu. Also note that all data for hgGeneGraph can be obtained through our public MySQL server and all our software source code is available and can be installed locally onto your own computer. If you are unsure how to use these resources, do not hesitate to contact us.
UCSC Genome Browser Gene Interaction Graph
Gene interactions and pathways from curated databases and text-mining

◀ Back to MAPK7

CRH — MAPK7

Text-mined interactions from Literome

Grammatopoulos et al., Mol Endocrinol 2000 (MAP Kinase Signaling System) : We therefore hypothesized that activation of MAPK might mediate CRH and or/urocortin actions in the myometrium
Kovalovsky et al., Mol Endocrinol 2002 (MAP Kinase Signaling System) : The MAPK kinase inhibitors did not affect Nur77 and Nurr1 mRNA induction but blocked CRH or cAMP stimulated Nur transcriptional activity ... In conclusion, in AtT-20 corticotrophs the CRH/cAMP signaling that leads to Nur77/Nurr1 mRNA induction and transcriptional activation, and thus POMC expression, is dependent on protein kinase A and involves calcium/calmodulin kinase II ( Nur induction/activation ) and MAPK calcium dependent and -independent ( Nur phosphorylation-activation ) pathways
Park et al., J Invest Dermatol 2005 (MAP Kinase Signaling System) : In addition, CRH treatment induced rapid phosphorylation of p38 MAPK ... SB203580 were able to inhibit CRH induced p38 MAPK phosphorylation
Refojo et al., Proc Natl Acad Sci U S A 2005 : Corticotropin releasing hormone activates ERK1/2 MAPK in specific brain areas
Cheng et al., Life Sci 2005 : In this study, we showed that the MAPK inhibitor, PD098059, causes a dose dependent inhibition of placental CRH gene expression
Basta-Kaim et al., Neuropharmacology 2005 (Neuroblastoma) : It was found that wortmannin ( 0.1muM ), an inhibitor of phosphatidylinositol 3-kinase (PI3-K) and forskolin ( 10, 25muM ), an activator of adenylate cyclase enhanced the basal activity of CRH gene promoter, whereas inhibitors of protein kinase A, calcium/calmodulin kinase ( CaMK ) and mitogen activated protein kinase ( MAPK ) had opposite effects
Cao et al., Mol Pharmacol 2006 : CRH also induced rapid phosphorylation of p38 MAPK , which was mimicked by 8-bromo-cAMP and was inhibited by H89 or SB203580
Swinny et al., Eur J Neurosci 2006 : The structural effects of CRF required protein kinase A and mitogen activated protein kinase , as well as Rac1, a member of the Rho family of GTPases that regulates the actin and microtubule cytoskeleton
Wang et al., Placenta 2007 : Stimulation of the cells with CRH caused a rapid and transient phosphorylation of p38/MAPK while CRH had no effect on ERK1/2 activation ... The effect of CRH on p38/MAPK activation was suppressed by astressin and by the p38/MAPK inhibitor SB203580
Zhang et al., Br J Pharmacol 2009 : These findings suggest that Ucn1 exerts pro-inflammatory effects by augmenting LPS induced expression of COX-2 and ICAM-1 in RAECs via CRF ( 2 ) receptors and the activation of p38MAPK and NF-kappaB
Zhou et al., Regul Pept 2010 : In addition, CRH treatment induced rapid phosphorylation of p38 MAPK and JNK1/2, and antalarmin, SB203580 and SP600125 inhibited CRH induced phosphorylation of p38 MAPK and JNK1/2